지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 질병관리본부 Osong Public Health and Research Persptectives Osong Public Health and Research Perspectives 제12권 제6호
- 발행연도
- 2021.12
- 수록면
- 396 - 402 (7page)
- DOI
- 10.24171/j.phrp.2021.0310
이용수
초록· 키워드
오류제보하기
Objectives: This study aimed to present data on reported adverse events following coronavirus disease 2019 (COVID-19) vaccination in Republic of Korea from February 26 to October 31, 2021, and to determine whether any significant patterns emerged from an analysis of the characteristics of suspected adverse event cases for each type of vaccine.Methods: Adverse events following COVID-19 vaccination reported by medical doctors and forensic pathologists were analyzed. Cases of suspected anaphylaxis were classified using the Brighton Collaboration definition.Results: By October 31, 2021, a total of 353,535 (0.45%) adverse events were reported after 78,416,802 COVID-19 vaccine doses. Of the adverse events, 96.4% were non-serious and 3.6% were serious. The most frequently reported adverse events were headache, myalgia, and dizziness. Of the 835 reported deaths after COVID-19 vaccination, 2 vaccine-related deaths were confirmed. Suspected anaphylaxis was confirmed in 454 cases using the Brighton Collaboration definition.Conclusion: The commonly reported symptoms were similar to those described in clinical trials. Most reported adverse events were non-serious, and the reporting rate of adverse events following COVID-19 vaccination was higher in women than in men (581 vs. 315 per 100,000 vaccinations). Confirmed anaphylaxis was reported in 5.8 cases per 1,000,000 vaccinations.
목차
등록된 정보가 없습니다.
참고문헌 (10)
참고문헌 신청
Korea Disease Control and Prevention Agency / 2021 / Update on COVID-19 and COVID-19 vaccination / KDCA
European Medicines Agency(EMA) / 2021 / Press briefing on the conclusion of the assessment of the Pharmacovigilance Risk Assessment Committee (PRAC) of Vaxzevria (previously COVID-19 Vaccine AstraZeneca) and thromboembolic events / EMA
Korea Disease Control and Prevention Agency / 2021 / Updated action plan for COVID-19 vaccination 2021 / KDCA
Lee E / 2021 / Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021 / Euro Surveill 26:2100694
Medicines and Healthcare Products Regulatory Agency / Summary of yellow card reporting
European Medicines Agency(EMA) / 2021 / Press briefing on the conclusion of the assessment of the Pharmacovigilance Risk Assessment Committee (PRAC) of Vaxzevria (previously COVID-19 Vaccine AstraZeneca) and thromboembolic events / EMA
Korea Disease Control and Prevention Agency / 2021 / Updated action plan for COVID-19 vaccination 2021 / KDCA
Lee E / 2021 / Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021 / Euro Surveill 26:2100694
Medicines and Healthcare Products Regulatory Agency / Summary of yellow card reporting
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
COVID-19 vaccine safety monitoring in the Republic of Korea: February 26, 2021 to April 30, 2021
Osong Public Health and Research Persptectives
2021 .08
-
Adverse events and preventive measures related to COVID-19 vaccines
Clinical and Experimental Emergency Medicine
2021 .09
-
Post-vaccination COVID-19 deaths: a review of available evidence and recommendations for the global population
Clinical and Experimental Vaccine Research
2021 .09
-
COVID-19 Vaccination in Korea
Infection and Chemotherapy
2023 .03
-
Should steroids be used for anaphylaxis after the COVID-19 vaccine?
Clinical and Experimental Emergency Medicine
2021 .12
-
Factors Associated with Adverse Events Following the First Dose of COVID-19 Immunization in Indonesia
성인간호학회지
2022 .06
-
코로나-19 백신 예방접종 후 이상반응으로 중증응급진료센터를 내원한 환자분석: 다기관 후향적 관찰연구
대한응급의학회지
2024 .02
-
Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers
Yonsei Medical Journal
2021 .12
-
일개 한의과대학 재학생의 COVID-19 백신 접종에 대한 인식 조사
대한예방한의학회지
2021 .12
-
소아청소년에서 Coronavirus Disease 2019 백신에 대한 이상 반응
Allergy Asthma & Respiratory Diseases
2022 .01
-
Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center study
Clinical and Experimental Vaccine Research
2021 .09
-
Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older
Journal of Korean Medical Science
2021 .11
-
Efficacy and Safety of COVID-19 Vaccines in Adolescents: Systematic Review of Randomized Controlled Studies and Observational Studies
Pediatric Infection and Vaccine
2024 .04
-
코로나19 예방접종센터에서 BNT162b2 mRNA COVID-19 백신 접종 후 발생한 이상반응 환자의 임상 특성
대한응급의학회지
2022 .04
-
항공종사자와 코로나바이러스감염증-19 백신 예방 접종
항공우주의학회지
2021 .04
-
Autoimmune Encephalitis as an Adverse Event of COVID-19 Vaccination
Journal of Clinical Neurology
2022 .01
-
Who Influences the Public Intention to Get a COVID-19 Vaccine and What are the Public References and Concerns? A Population Survey in Vietnam
Infection and Chemotherapy
2021 .12
-
Relationship Between Coronavirus Disease 2019 Vaccination Rates and Rare But Potentially Fatal Adverse Events: A Regression Discontinuity Analysis of Western Countries
Journal of Korean Medical Science
2023 .03
-
Adverse events following pediatric immunization in an Indian city
Clinical and Experimental Vaccine Research
2021 .09
-
Association of COVID-19 vaccine attitudes and cognitions of COVID-19-related stigma with vaccine hesitancy among college students
한국간호교육학회지
2022 .08
이 논문의 저자 정보
최근 본 자료
댓글(0)
0